Poonam R Velagaleti

This inventor holds 6 USPTO granted patents and 5 published patent applications, plus 3 CIPO patents and 1 EPO patent. Top assignees: Aurinia Pharmaceuticals, Inc., Lux Biosciences, Inc., Inovion, Inc.. Active years: 2013-2021.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Poonam R Velagaleti. Retrieved from https://idiyas.com/inventor/poonam-r-velagaleti

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 6 (Patent Applications = 5)

% Patents Active = 100.0

CIPO Patents = 3

EPO Patents = 1 (Patent Applications = 3)

Average Co-Inventor Count = 3.2

ph-index = 4

Forward Citations = 68(Granted Patents)

Company Filing History:

3 out of 8

Aurinia Pharmaceuticals, Inc.

patents

2 out of 2

Lux Biosciences, Inc.

Years Active: 2013-2021

Loading Chart...

6 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10973871 - Ophthalmic compositions (2021-04-13),

2. 10265375 - Ophthalmic compositions (2019-04-23),

3. 10207003 - Liquid pentablock co-polymer formulations for sustained delivery of therapeutics (2019-02-19),

4. 9017725 - Topical drug delivery systems for ophthalmic use (2015-04-28),

5. 8535694 - Ophthalmic compositions comprising calcineurin inhibitors or mTOR inhibitors (2013-09-17),

6. 8435544 - Ophthalmic compositions comprising calcineurin inhibitors or mTOR inhibitors (2013-05-07),

Title: The Innovative Contributions of Poonam R Velagaleti

Introduction

Poonam R Velagaleti is an accomplished inventor based in Randolph, NJ, who has made significant strides in the field of ophthalmic compositions. With a total of six patents to her name, her work has focused on developing innovative solutions for ocular diseases and conditions.

Latest Patents

Her most recent patents involve ophthalmic compositions that utilize calcineurin inhibitors and mTOR inhibitors. These compositions are designed to effectively treat various ocular diseases and conditions. The patents detail pharmaceutical formulations that include specific surfactants with precise HLB indices, enabling the formation of mixed micelles that enhance the delivery of the therapeutic agents.

Career Highlights

Poonam has honed her expertise through her associations with notable companies such as Aurinia Pharmaceuticals, Inc. and Lux Biosciences, Inc. Her experience in these organizations has enabled her to contribute significantly to the field of pharmaceuticals, particularly in developing treatments for eye-related health issues.

Collaborations

Throughout her career, Poonam has collaborated with esteemed colleagues, including Ashim K Mitra and Subramanian Natesan. These partnerships have further enriched her research and innovation efforts, and together they have worked towards advancing ophthalmic therapies.

Conclusion

Poonam R Velagaleti stands out as a trailblazer in the innovation of ophthalmic compositions. Her dedication to developing effective treatments is reflected in her patents and her collaborations within the pharmaceutical industry, making her a prominent figure in the realm of inventions aimed at improving eye health.

Profile summary based on public USPTO records.